HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 481-492 of 1,811
Drug study icon
CompletedEUCTR 2011-004668-31

A Phase 3, Open-label, Multicentre, Protocol to Provide Access to Guanfacine Hydrochloride Extended Release for European Subjects with Attention-deficit/Hyperactivity Disorder (ADHD) who Participat...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Austria
ADHDHistorical research record
Countries
United Kingdom, Belgium, Austria, + 7 others
Sponsor
Shire Pharmaceutical Development Ltd
Drug study icon
CompletedEUCTR 2010-020951-30

A Phase 4, Open-label, Multicentre, 2-Year Safety Study of Lisdexamfetamine Dimesylate in Children and Adolescents Aged 6-17 Years with Attention-Deficit/Hyperactivity Disorder (ADHD)

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Belgium
ADHDHistorical research record
Countries
United Kingdom, Belgium, Germany, + 6 others
Sponsor
Shire Pharmaceutical Development Ltd
Biological study icon
CompletedEUCTR 2016-002171-94

Effectiveness of a personalized Neurofeedback Training device (ADHD@Home) as compared with Methylphenidate in the treatment of children and adolescents with Attention-Deficit/Hyperactivity Disorder...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Belgium
ADHDHistorical research record
Countries
Belgium, Spain
Sponsor
Mensia Technologies SA
Drug study icon
CompletedEUCTR 2010-024551-82

OPEN LABEL TRIAL OF ATOMOXETINE FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN CHILDREN WITH 22q11.2 DELETION SYNDROME (22qDS)

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In United Kingdom
ADHDHistorical research record
Countries
United Kingdom
Sponsor
King's College London [...] 1. King's College London 2. South London and Maudsley NHS Foundation Trust
Drug study icon
CompletedEUCTR 2007-007672-41

Protocol B4Z-MC-LYDO(b) Maintenance of Response After Open-Label Treatment with Atomoxetine Hydrochloride in Adult Outpatients with Attention-Deficit/Hyperactivity Disorder (ADHD): A Placebo-Cont...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Austria
ADHDHistorical research record
Countries
France, United Kingdom, Belgium, + 9 others
Sponsor
Eli Lilly and Company
Drug study icon
CompletedEUCTR 2015-004271-78

Randomised controlled trial of the short term effects of OROS-methylphenidate on ADHD symptoms and behavioural outcomes in young male prisoners with attention deficit hyperactivity disorder

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In United Kingdom
ADHDHistorical research record
Countries
United Kingdom
Sponsor
King's College London (University)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.